Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Dr Reddy's Laboratories-ADRRDY18.423.333.390.0019.27%8.19%40.49$66.94$61.7946,359$14.20

Detail of Dr Reddy's Laboratories-ADR

 
CEO
Mr. Erez Israeli M.B.A.
Employees
27048
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$998B

Company details

Dr. Reddy's Laboratories Ltd. is a prominent pharmaceutical company, engaged in the research, development, manufacturing, and marketing of a wide array of generic medicines, active pharmaceutical ingredients (APIs), and biosimilars. Founded in 1984, the company plays a critical role in providing affordable healthcare solutions on a global scale. Dr. Reddy's Laboratories is known for its robust product portfolio that extends across various therapeutic areas, including oncology, gastroenterology, cardiovascular, and dermatology. The company's global footprint spans both emerging markets and developed economies, allowing it to serve diverse patient populations and adhere to different regulatory landscapes. In the financial markets, Dr. Reddy's Laboratories is significant due to its contribution to the healthcare sector, providing alternatives to high-priced medications and promoting access to essential drugs. As part of its commitment to addressing health challenges, the company invests heavily in research and innovation to meet the evolving needs of patients worldwide. Dr. Reddy's not only impacts the pharmaceutical industry but also contributes to the broader life sciences market with its focus on sustainability and compliance with international quality standards.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$311.30B
Cost of goods (CoG)
-$126.66B
Gross profit (GP)
$184.65B
Operating expense (OE)
-$116.70B
Research and development (R&D)
-$27.00B
General and administrative (G&A)
-$90.29B
Other (OTH)
$586.00M
Operating income (OI)
$67.94B
Other income expense (OIE)
-$4.12B
Pretax income (PI)
$72.75B
Tax (TAX)
-$18.30B
Net income (NI)
$54.44B
Dr Reddy's Laboratories-ADR
RDY • XNYS • US
$14.20
-61.29 (-81.19%)
Stock vs Industry average
  • Industry average

Dividend yield
3.37%
Trailing annual dividend rate
$0.479174
Payout ratio
12.39%
EPS
$0.76
Margin profit
17.24%
52 week low
$13.99
52 week high
$84.209999
50-day simple moving average
$0.00
200-day simple moving average
$66.94
Percent held by insiders
0.03%
Percent held by institutions
15.00%
Dividend yield
3.61%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
RDY -81.19%
eps change
RDY -79.52%